|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.05 SEK | -1.98% |
|
-0.67% | +28.65% |
| 03-02 | 12 Stocks Reach New 52-Week Highs on the Stockholm Stock Exchange Today | FW |
| 03-02 | Handelsbanken Raises Target Price for Cloetta to 58 Kronor (from 52), Reiterates Buy - BN | FW |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.37 | 3.77 | 2.91 | 4.7 | 5.16 | |||||
Return on Total Capital | 4.62 | 5.22 | 4.02 | 6.55 | 7.23 | |||||
Return On Equity % | 6.71 | 10.89 | 5.78 | 8.66 | 9.06 | |||||
Return on Common Equity | 6.71 | 10.89 | 5.78 | 8.66 | 9.06 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 35.08 | 35.53 | 31.02 | 31.3 | 32.98 | |||||
SG&A Margin | 26.13 | 26.15 | 24.3 | 21.78 | 22.52 | |||||
EBITDA Margin % | 12.2 | 12.29 | 9.39 | 11.89 | 12.76 | |||||
EBITA Margin % | 9.13 | 9.54 | 6.89 | 9.65 | 10.6 | |||||
EBIT Margin % | 8.96 | 9.38 | 6.73 | 9.52 | 10.46 | |||||
Income From Continuing Operations Margin % | 4.93 | 7.81 | 4 | 5.26 | 5.54 | |||||
Net Income Margin % | 4.93 | 7.81 | 4 | 5.26 | 5.54 | |||||
Net Avail. For Common Margin % | 4.93 | 7.81 | 4 | 5.26 | 5.54 | |||||
Normalized Net Income Margin | 5.03 | 5.84 | 3.12 | 4.77 | 5.53 | |||||
Levered Free Cash Flow Margin | 5.41 | 9.48 | 0.69 | 4.29 | 5.58 | |||||
Unlevered Free Cash Flow Margin | 5.77 | 9.78 | 0.59 | 5.73 | 6.84 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.6 | 0.64 | 0.69 | 0.79 | 0.79 | |||||
Fixed Assets Turnover | 3.65 | 3.86 | 4.35 | 5.08 | 5.09 | |||||
Receivables Turnover (Average Receivables) | 7.75 | 8.93 | 8.44 | 8.75 | 8.51 | |||||
Inventory Turnover (Average Inventory) | 4.01 | 4.34 | 4.9 | 4.79 | 4.39 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.58 | 1.56 | 1.63 | 1.66 | 1.82 | |||||
Quick Ratio | 0.31 | 0.98 | 0.96 | 0.94 | 1.11 | |||||
Operating Cash Flow to Current Liabilities | 0.18 | 0.57 | 0.3 | 0.42 | 0.39 | |||||
Days Sales Outstanding (Average Receivables) | 47.2 | 40.87 | 43.23 | 41.73 | 43.02 | |||||
Days Outstanding Inventory (Average Inventory) | 91.33 | 84.04 | 74.46 | 76.23 | 83.32 | |||||
Average Days Payable Outstanding | 47.07 | 47.88 | 40.31 | 40.12 | 42.95 | |||||
Cash Conversion Cycle (Average Days) | 91.46 | 77.03 | 77.38 | 77.84 | 83.4 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 60.61 | 52.45 | 49.74 | 48.9 | 47.07 | |||||
Total Debt / Total Capital | 37.74 | 34.4 | 33.22 | 32.84 | 32.01 | |||||
LT Debt/Equity | 2.66 | 47.88 | 45.59 | 44.57 | 42.51 | |||||
Long-Term Debt / Total Capital | 1.65 | 31.41 | 30.45 | 29.93 | 28.9 | |||||
Total Liabilities / Total Assets | 54.86 | 52.72 | 51.59 | 52.28 | 51.24 | |||||
EBIT / Interest Expense | 15.45 | 19.55 | -42 | 4.14 | 5.21 | |||||
EBITDA / Interest Expense | 23.27 | 27.97 | -65.55 | 5.99 | 6.85 | |||||
(EBITDA - Capex) / Interest Expense | 15.18 | 21.31 | -46.27 | 4.53 | 5.91 | |||||
Total Debt / EBITDA | 3.3 | 2.92 | 3.45 | 2.18 | 2.16 | |||||
Net Debt / EBITDA | 2.78 | 2.07 | 2.59 | 1.59 | 1.35 | |||||
Total Debt / (EBITDA - Capex) | 5.06 | 3.83 | 4.88 | 2.88 | 2.5 | |||||
Net Debt / (EBITDA - Capex) | 4.27 | 2.71 | 3.67 | 2.1 | 1.57 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -12.29 | 6.16 | 13.61 | 20.85 | 3.76 | |||||
Gross Profit, 1 Yr. Growth % | -16.09 | 7.62 | -0.75 | 10.98 | 9.35 | |||||
EBITDA, 1 Yr. Growth % | -25.03 | 10.07 | -13.07 | 13.45 | 11.12 | |||||
EBITA, 1 Yr. Growth % | -30.2 | 15.4 | -17.88 | 14.76 | 13.7 | |||||
EBIT, 1 Yr. Growth % | -30.52 | 15.71 | -18.37 | 14.99 | 14.05 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -43.57 | 78.11 | -41.74 | 58.91 | 9.15 | |||||
Net Income, 1 Yr. Growth % | -43.57 | 78.11 | -41.74 | 58.91 | 9.15 | |||||
Normalized Net Income, 1 Yr. Growth % | -31.23 | 29 | -39.18 | 11.62 | 20.19 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -43.61 | 78.26 | -41.53 | 59.57 | 9.13 | |||||
Accounts Receivable, 1 Yr. Growth % | -21.51 | 9.6 | 29.8 | 6.53 | 6.84 | |||||
Inventory, 1 Yr. Growth % | 6.61 | -11.45 | 29.3 | 18.53 | 3.41 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.06 | 1.03 | 0.32 | 6.64 | 0.53 | |||||
Total Assets, 1 Yr. Growth % | -4.17 | 3.48 | 8.03 | 3.56 | 4.32 | |||||
Tangible Book Value, 1 Yr. Growth % | -6.93 | -22.51 | -16.68 | -14.06 | -47.77 | |||||
Common Equity, 1 Yr. Growth % | -0.43 | 8.72 | 10.61 | 2.08 | 6.59 | |||||
Cash From Operations, 1 Yr. Growth % | -9.39 | 33.85 | -39.51 | 49.9 | -1.67 | |||||
Capital Expenditures, 1 Yr. Growth % | 59.88 | -27.72 | 9.84 | 32.08 | -42.14 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 27.39 | 84.55 | -91.68 | 22.78 | 63.4 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 24.64 | 78.53 | -93.1 | 67.89 | 42.39 | |||||
Dividend Per Share, 1 Yr. Growth % | 50 | 33.33 | 0 | 0 | 10 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -4.3 | -3.5 | 9.82 | 17.17 | 11.98 | |||||
Gross Profit, 2 Yr. CAGR % | -6.41 | -5.02 | 3.33 | 10 | 10.16 | |||||
EBITDA, 2 Yr. CAGR % | -10.26 | -10.47 | -2.25 | 15.33 | 12.39 | |||||
EBITA, 2 Yr. CAGR % | -12.49 | -11.99 | -2.74 | 17.92 | 14.37 | |||||
EBIT, 2 Yr. CAGR % | -12.56 | -12.11 | -2.9 | 18.14 | 14.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -23.73 | -2.65 | 1.87 | -3.78 | 31.7 | |||||
Net Income, 2 Yr. CAGR % | -23.73 | -2.65 | 1.87 | -3.78 | 31.7 | |||||
Normalized Net Income, 2 Yr. CAGR % | -11.06 | -7.89 | -11.51 | 6.02 | 15.83 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -23.62 | -2.85 | 2.09 | -3.41 | 31.96 | |||||
Accounts Receivable, 2 Yr. CAGR % | -6.88 | -7.25 | 19.27 | 17.59 | 6.69 | |||||
Inventory, 2 Yr. CAGR % | 11.05 | -2.84 | 7 | 23.8 | 10.71 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.34 | 0.54 | 0.67 | 3.43 | 3.54 | |||||
Total Assets, 2 Yr. CAGR % | 0.48 | -0.58 | 5.73 | 5.77 | 3.94 | |||||
Tangible Book Value, 2 Yr. CAGR % | -8.64 | -15.29 | -19.65 | -15.38 | -33.01 | |||||
Common Equity, 2 Yr. CAGR % | 2.62 | 3.72 | 9.66 | 6.26 | 4.31 | |||||
Cash From Operations, 2 Yr. CAGR % | 2.2 | 8.86 | -10.02 | -4.78 | 21.41 | |||||
Capital Expenditures, 2 Yr. CAGR % | 28.78 | 7.5 | -10.89 | 20.45 | -12.58 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -12.08 | 53.95 | -60.84 | -21.11 | 28.73 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -13.55 | 49.74 | -64.93 | -10.26 | 44.19 | |||||
Dividend Per Share, 2 Yr. CAGR % | -13.4 | 41.42 | 15.47 | 0 | 4.88 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.52 | -0.93 | 1.89 | 13.38 | 12.52 | |||||
Gross Profit, 3 Yr. CAGR % | -2.34 | -1.98 | -3.63 | 9.18 | 9.79 | |||||
EBITDA, 3 Yr. CAGR % | -4.18 | -4.87 | -11.39 | 13.5 | 13.99 | |||||
EBITA, 3 Yr. CAGR % | -4.87 | -5.28 | -14.05 | 17.01 | 16.6 | |||||
EBIT, 3 Yr. CAGR % | -4.9 | -5.27 | -14.3 | 17.26 | 16.76 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 5.84 | -0.76 | -17.96 | 18.14 | 0.35 | |||||
Net Income, 3 Yr. CAGR % | 42.55 | -0.76 | -17.96 | 18.14 | 0.35 | |||||
Normalized Net Income, 3 Yr. CAGR % | -4.14 | -0.81 | -19.84 | 13.12 | 10.55 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 5.79 | -0.8 | -17.98 | 18.48 | 0.6 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.34 | -1.68 | 3.75 | 14.86 | 13.89 | |||||
Inventory, 3 Yr. CAGR % | 8.52 | 2.98 | 6.87 | 10.72 | 16.59 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 5.25 | 5.19 | 0.47 | 2.62 | 2.46 | |||||
Total Assets, 3 Yr. CAGR % | 0.02 | 1.37 | 2.21 | 5 | 5.29 | |||||
Tangible Book Value, 3 Yr. CAGR % | -6.11 | -13.66 | -15.76 | -17.83 | -27.96 | |||||
Common Equity, 3 Yr. CAGR % | 3.06 | 4.4 | 5.97 | 7.07 | 6.37 | |||||
Cash From Operations, 3 Yr. CAGR % | -2.69 | 10.96 | -10.5 | 6.67 | -3.75 | |||||
Capital Expenditures, 3 Yr. CAGR % | 25.22 | 6.23 | 8.28 | 1.6 | -5.67 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -25.25 | 12.87 | -41.82 | 4.69 | -5.65 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -24.62 | 10.37 | -46.34 | 12.83 | -0.09 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0 | 0 | 25.99 | 10.06 | 3.23 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 0.07 | 3.43 | 3.5 | 5.95 | 5.81 | |||||
Gross Profit, 5 Yr. CAGR % | -2.2 | 1.06 | -0.13 | 2.64 | 3.6 | |||||
EBITDA, 5 Yr. CAGR % | -4.39 | -2.9 | -3.97 | 2.72 | 3.46 | |||||
EBITA, 5 Yr. CAGR % | -5.03 | -3.49 | -4.77 | 3.36 | 4.15 | |||||
EBIT, 5 Yr. CAGR % | -5.28 | -3.68 | -4.87 | 3.44 | 4.19 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -6.15 | 6.35 | 3.02 | -1.98 | -0.86 | |||||
Net Income, 5 Yr. CAGR % | -6.15 | 19.83 | 23.17 | -1.98 | -0.86 | |||||
Normalized Net Income, 5 Yr. CAGR % | -2.05 | 0.21 | -7.99 | 1.83 | 2.73 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -6.18 | 6.27 | 2.98 | -1.85 | -0.8 | |||||
Accounts Receivable, 5 Yr. CAGR % | -6.19 | -4.79 | 4.48 | 5.61 | 4.91 | |||||
Inventory, 5 Yr. CAGR % | 3.91 | 1.57 | 7.91 | 10.85 | 8.39 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -1.68 | -1.5 | 3.39 | 4.48 | 1.69 | |||||
Total Assets, 5 Yr. CAGR % | -1.05 | 0.67 | 2.2 | 3.11 | 2.9 | |||||
Tangible Book Value, 5 Yr. CAGR % | -2.91 | -1.57 | -11.87 | -14.36 | -23.13 | |||||
Common Equity, 5 Yr. CAGR % | -0.77 | 1.46 | 5.52 | 5.14 | 5.3 | |||||
Cash From Operations, 5 Yr. CAGR % | -6.68 | -0.71 | -6.13 | 4.38 | 1.11 | |||||
Capital Expenditures, 5 Yr. CAGR % | 14.11 | 4.48 | 9.28 | 11.7 | -0.61 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -14.69 | 10.79 | -42.19 | -2.22 | 14.74 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -15.72 | 7.68 | -44.41 | 1.58 | 17.44 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.45 | 5.92 | 5.92 | 0 | 17.08 |
- Stock Market
- Equities
- CLA B Stock
- Financials Cloetta AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















